Michael Aberman

Director/Board Member at

Halomine, Inc.

55 year

98 connections

Health Technology

Consumer Services

Finance

Profile

Michael S.
Aberman is the founder of Xenimmune Therapeutics, Inc. Current jobs include Director at Halomine, Inc. since 2021 and General Partner at Regeneron Ventures since 2024.
Former jobs include President & Chief Executive Officer at Quentis Therapeutics, Inc., Director-Business Development at Agenus, Inc. in 2004, Research Analyst at Credit Suisse Securities (USA) LLC from 2006 to 2010, Senior VP-Strategy & Investor Relations at Regeneron Pharmaceuticals, Inc., and Research Associate at Morgan Stanley & Co. LLC from 2004 to 2006.
Education includes an undergraduate degree from Cornell University in 1993, a doctorate from the University of Toronto in 1997, and an MBA from The Wharton School of the University of Pennsylvania in 2001.

Michael Aberman active positions

Companies	Position	Start
Halomine, Inc. Halomine, Inc. Industrial SpecialtiesProcess Industries Manufactures chlorine disinfectants for surfaces and medical devices	Director/Board Member	03/11/2021

All active positions of Michael Aberman

Former positions of Michael Aberman

Companies	Position	End
Credit Suisse Securities (USA) LLC (Broker) Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	21/03/2010
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31/05/2006
AGENUS INC.	Corporate Officer/Principal	01/03/2004
Xenimmune Therapeutics, Inc. Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection	Founder	-
Quentis Therapeutics, Inc. Quentis Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics	Chief Executive Officer	-

See the detail of Michael Aberman's experience

Training of Michael Aberman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Aberman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Credit Suisse Securities (USA) LLC (Broker) Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases	Health Technology
Agenus, Inc. Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases	Health Technology
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Quentis Therapeutics, Inc. Quentis Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics	Health Technology
Halomine, Inc. Halomine, Inc. Industrial SpecialtiesProcess Industries Manufactures chlorine disinfectants for surfaces and medical devices	Process Industries
Xenimmune Therapeutics, Inc. Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection	Health Technology